Rezolute Inc. (RZLT)

[Monksdream]

RXLT under $2

[BurgerKing82]

This one looks good....What's the timeframe for a 5X

[Whalatane]

CMO buying
http://archive.fast-edgar.com/20240221/AP22V222E22252T2222D2CO2PM7AU222B262/
His and the CFO's were open market purchases

Kiwi

[Whalatane]

Thx ...the more DD the better ...including informed opposing opinions
Re price targets ...I'm the last person to ask that .
I owned SLNO in the $ 2's . Thought it might triple on good P 3 results . In fact it ran up to $20 ,,,,at which time I sold .
It's now trading at $48 a share !!!!!

You might look at UNCY also . My wife rounds dialysis clinics. None of her patients are at serum phosphorous goals as they hate the current meds
Near term catalyst will be Co announcing pivotal trial is fully enrolled.

VERA is another Co I'm invested in. They appear to have a functional cure for IgAN ( kidney disease ).

All the above are very speculative and are vulnerable to sell off's on any increase in interest rates ...let alone bad data readouts .
Let me know if U look at UNCY

Kiwi

[GD]

Thanks for the DD and reply. From the PR on DEC 13th, the statements are as bullish
as they can be, IMO, assume P2 data is strong positive, what may be the fair price
target in your opinion? Thanks to your mentioning on Biotech value board, I did some
reading last night and like the reward/risk, so I bought in this morning.

[Whalatane]

Well congrats if you are in EYPT . There are some differences between DME and wAMD ...from ChatGPT

Wet AMD is characterized by the growth of abnormal blood vessels, also known as choroidal neovascularization (CNV), which leak fluid and blood into the macula, leading to rapid vision loss if left untreated.
Treatments for wet AMD often involve anti-vascular endothelial growth factor (anti-VEGF) injections or other therapies aimed at stopping the growth of abnormal blood vessels.
DME (Diabetic Macular Edema):
DME is a complication of diabetic retinopathy, which is a condition caused by damage to the blood vessels in the retina due to diabetes.
In DME, the blood vessels in the retina become leaky, leading to fluid accumulation (edema) in the macula.
This accumulation of fluid causes the macula to swell, leading to blurry or distorted vision, and if left untreated, it can cause vision loss.
Treatments for DME often involve anti-VEGF injections, corticosteroid injections, or laser therapy aimed at reducing the leakage of fluid and improving vision.

In summary, while both wet AMD and DME involve fluid accumulation in the macula leading to vision problems, wet AMD is primarily related to abnormal blood vessel growth due to aging, while DME is a complication of diabetic retinopathy resulting from diabetes-related damage to retinal blood vessels.

So the disease process is different ...DME specific to diabetics with the MOA ( method of action ) of RZ402 primarily being anti inflammatory / anti leakage .....not slowing / preventing abnormal growth of blood vessels ( wAMD )

Just my layman's take on this ...Thx for your question as its lead me to more research in the area.

They are hoping RZ402 can be used as an easy treatment for the early stages of DME.

Kiwi

[GD]

Kiwi, We see EYPT has an EYP-1901 P2 for DME, Does RZ402 have potential
for wAMD?

[Whalatane]

CFO buying http://archive.fast-edgar.com/20240220/AP27R222E222H2S2222A2CO2NABDZ222B262/

Kiwi

[Whalatane]

RZ402 is the near term catalyst . P2 data on DME ...with 3 doses 50mg, 200 mg and 400mg .
The 50mg and and 200 mg dose were shown similar to placebo in safety profile. Believe this is the first time using 400 mg dose .
Trial is fully enrolled with 94 patients
12 wk trial followed by 4 wk follow up
Data mid / late Q2 2024.
High risk spec , some talented people in the Co
Kiwi

[sc00pnDump]

Rezolute, Inc. (Nasdaq: RZLT), a clinical-stage biopharmaceutical company committed to developing novel, transformative therapies for serious metabolic and rare diseases, today announced that the European Medicines Agency (EMA) has granted Priority Medicines (PRIME) eligibility to RZ358 for the treatment of congenital hyperinsulinism (HI).

Read 8k yesterday news

[sc00pnDump]

8k out granted Rz358

[Monksdream]

RZLT new 52 week low

[Monksdream]

RZLT new 52 week low

[Monksdream]

RXLT new 52=week low

[weedtrader420]

RZLT🤑

[Monksdream]

RZLT new 52 week low

[Monksdream]

RZLT under $2

[saigai]

rzlt insider buys
Rezolute Director Gil Labrucherie Buys $199,997.80
Rezolute SVP Brian Kenneth Roberts Buys $79,997.60

[saigai]

great data and then.. the offering.. shoot me

[saigai]

well the numbers are out on sunday.. holding 4k shares...into the news....

[saigai]

idont care if im talking to myself.. this is going to 40 bucks.. in the near term.. so to all the criminals out there gfy

[saigai]

soon they will be sending hit men to your door ....belly up and pay retail criminals mofos

[saigai]

pre mkt down 10percent on 1 share traded...must be getting real close to the kaboom because the knives are out..

[saigai]

adding a few everyday...

[saigai]

from last nesw release im tellin you kaboom is coming

REDWOOD CITY, Calif., March 23, 2022 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT), a clinical-stage biopharmaceutical company dedicated to developing transformative therapies with the potential to disrupt current treatment paradigms for devastating metabolic diseases, today announced positive data from its Phase 2b RIZE study of RZ358. The data demonstrated the safety and tolerability of RZ358 in patients with congenital hyperinsulinism, as well as highly significant improvements in hypoglycemia. The RIZE study results will be presented in an oral presentation at an upcoming medical congress in 2Q 2022, followed by a conference call hosted by the Company to discuss the data.

“We are very encouraged by the results and are looking forward to moving the program into Phase 3,” said Nevan Charles Elam, CEO and Founder of Rezolute. Mr. Elam continued, “We are very grateful to the patients, their families, patient advocacy organizations, and the investigators who participated in this study. I also appreciate the tremendous dedication of the Rezolute team, who are mission driven to develop an innovative treatment option for this debilitating condition.”

[saigai]

no buying into the close.. oh well. the next couple of days could get dicey

[saigai]

they drop it i buy . just 10 at a time . it adds up.

[saigai]

institutional investors snacking on the bid. sooner or later that cant live there..lock em up folks

[saigai]

chit close thought we would have a better day. its coming but this is the top until the data

[saigai]

where is everyone.

[saigai]

everytime the criminals drop it i buy more.

[saigai]

strap in folks we are going on a wild one

[saigai]

strong close ....zip code changer in the making

[saigai]

from nasdaq website follow the money

https://www.nasdaq.com/market-activity/stocks/rzlt/institutional-holdings

[saigai]

and another 500 at the buzzer..this is my waterloo and exrof. i need one or the other or my trading days are OVER!!! glta.. i dont think i ever believed more strongly in than i do these 2 companies good lucky to anyone with me!!!

[saigai]

i wish there was someone else out there watching this tape. this is the most incredible price action/criminality ive seen in a while..but i am gonna be here for the big big money or where the dunce cap. time will tell

[saigai]

i know im talking to myself but this is the weirdest price action ive seen in a very long time.. not day to day but during the day.. something is cookin here. bought a few more ..cant help myself

[saigai]

another jumpy day with little price movement. i dont know if it short covering delicately or institutional accumulation with saint like patience. holding for what should be off the charts data

[saigai]

well the bid ask is really jumpy but the trend is not good so no more avg down. just holding for the data

[saigai]

avg down a little more waiting on the data

[saigai]

i dont think this board gonna stay quiet for much longer. i hope

[saigai]

run you mofo

[Mushyheaded]

Inc Genexine owns over 1000% of Rezolute Inc.

At least, according to Wall Street Zen [as of today, August 1, 2021]. I've seen stocks have over 100% shares owned by insiders... even 200%. But this? Wtf?

Can anyone explain this? Lmao.

screenshot: https://imgur.com/gallery/n0wUVa0

[Renee]

RZLT moved to the Nasdaq from the OTC:

https://otce.finra.org/otce/dailyList?viewType=Deletions

[daleb2130]

I sold 50% of mine at 22.50. I still think there is a reason they wanted to go to the Nasdaq and needed to raise 40 million. I expect big news soon.. Plus all those insider buys since the beginning of July. But who knows.

[TrendTrade2016]

Got mine...sold all at 21.00

[daleb2130]

Not yet on Ameritrade. . Just showing up as numbers.

The "Think or Swim" app shows it's trading with Level 2 and Times and sales as RZTLD

[TrendTrade2016]

Did you get you shares from the split

[daleb2130]

Got to be some good news coming after the RS. I thought this might sell off bit. But, so far it doesn't look like it..

[TrendTrade2016]

wow 24 bucks...give me my shares!!